Literature DB >> 29788275

Feasibility and effectiveness of laparoscopic transgastric stapler-assisted circumferential esophageal mucosectomy and simultaneous fundoplication in a pig model.

D C Steinemann1,2, P C Müller1, A-C Schwarz1, A Zerz3, G R Linke1,4, B P Müller-Stich1.   

Abstract

Laparoscopic transgastric stapler-assisted mucosectomy (SAM) has been described for minimally invasive circumferential en bloc resection of Barrett's esophagus (BE). Conceivably long-term disease control might be achieved by adding antireflux surgery after resection of BE by SAM. The aim of this study was to assess the feasibility of combined SAM and fundoplication in one laparoscopic procedure in six pigs. Furthermore, the competence of the gastroesophageal junction (GEJ) was assessed at baseline, after SAM, and after subsequent laparoscopic fundoplication. At each measuring point reflux measurements were repeated 6 times in each pig. Blue-colored water was infused into the stomach to provoke reflux. Intragastric yield pressure and volume were recorded until drainage of blue solution (DBS) was noted. Time to reflux was measured by DBS and by multichannel intraluminal impedance (MII). In all animals SAM followed by laparoscopic fundoplication was feasible in a single session. A weakening of the GEJ was found after SAM, indicated by decreased yield pressure (11.5 mmHg vs. 8.5 mmHg; P < 0.001), time to DBS (90 seconds vs. 60 seconds; P = 0.008) and MII (80 seconds vs. 33 seconds; P < 0.001). After additional Nissen fundoplication the GEJ competence was restored, with measurements returning to baseline values (time to DBS 99 seconds; P = 0.15; MII 76 seconds; P = 0.84). The yield pressure increased from 11.5 mmHg at baseline to 19.7 mmHg after SAM and fundoplication (P < 0.001). Laparoscopic fundoplication and SAM may be combined in a single laparoscopic session. Although the GEJ was weakened after SAM, Nissen fundoplication restored the GEJ as an effective reflux barrier in this experiment. For clinical validation, the results need to be confirmed in a prospective human trial.

Entities:  

Mesh:

Year:  2018        PMID: 29788275      PMCID: PMC6124652          DOI: 10.1093/dote/doy030

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  31 in total

1.  Single-port live donor nephrectomy using a novel Curved Radius r2 Surgical System in an in vivo model.

Authors:  Marty Zdichavsky; Martina Krautwald; Tobias Meile; Dörte Wichmann; Jessica Lange; Alfred Königsrainer; Marc Oliver Schurr
Journal:  Minim Invasive Ther Allied Technol       Date:  2014-11-03       Impact factor: 2.442

2.  Stepwise radical endoscopic resection for eradication of Barrett's oesophagus with early neoplasia in a cohort of 169 patients.

Authors:  Roos E Pouw; Stefan Seewald; Joep J Gondrie; Pierre H Deprez; Hubert Piessevaux; Heiko Pohl; Thomas Rösch; Nib Soehendra; Jacques J Bergman
Journal:  Gut       Date:  2010-06-04       Impact factor: 23.059

3.  Surveillance in patients with long-segment Barrett's oesophagus: a cost-effectiveness analysis.

Authors:  F Kastelein; S van Olphen; E W Steyerberg; M Sikkema; M C W Spaander; C W N Looman; E J Kuipers; P D Siersema; M J Bruno; E W de Bekker-Grob
Journal:  Gut       Date:  2014-07-18       Impact factor: 23.059

4.  Laparoscopic transgastric esophageal mucosal resection: 4-year minimum follow-up.

Authors:  Constantine T Frantzides; Mark A Carlson; Ali Keshavarzian; Jacob E Roberts
Journal:  Am J Surg       Date:  2010-02-25       Impact factor: 2.565

5.  Long-term outcome of antireflux surgery in patients with Barrett's esophagus.

Authors:  W L Hofstetter; J H Peters; T R DeMeester; J A Hagen; S R DeMeester; P F Crookes; P Tsai; F Banki; C G Bremner
Journal:  Ann Surg       Date:  2001-10       Impact factor: 12.969

6.  Circumferential endoscopic mucosal resection in Barrett's esophagus with high-grade intraepithelial neoplasia or mucosal cancer. Preliminary results in 21 patients.

Authors:  M Giovannini; E Bories; C Pesenti; V Moutardier; G Monges; C Danisi; B Lelong; J R Delpero
Journal:  Endoscopy       Date:  2004-09       Impact factor: 10.093

7.  Esophageal stenosis after endoscopic mucosal resection of superficial esophageal lesions.

Authors:  Chikatoshi Katada; Manabu Muto; Tetsuro Manabe; Narikazu Boku; Atsushi Ohtsu; Shigeaki Yoshida
Journal:  Gastrointest Endosc       Date:  2003-02       Impact factor: 9.427

Review 8.  The effect of antireflux surgery on esophageal carcinogenesis in patients with barrett esophagus: a systematic review.

Authors:  Eugene Y Chang; Cynthia D Morris; Ann K Seltman; Robert W O'Rourke; Benjamin K Chan; John G Hunter; Blair A Jobe
Journal:  Ann Surg       Date:  2007-07       Impact factor: 12.969

Review 9.  Antireflux Surgery and Risk of Esophageal Adenocarcinoma: A Systematic Review and Meta-analysis.

Authors:  John Maret-Ouda; Peter Konings; Jesper Lagergren; Nele Brusselaers
Journal:  Ann Surg       Date:  2016-02       Impact factor: 12.969

10.  British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus.

Authors:  Rebecca C Fitzgerald; Massimiliano di Pietro; Krish Ragunath; Yeng Ang; Jin-Yong Kang; Peter Watson; Nigel Trudgill; Praful Patel; Philip V Kaye; Scott Sanders; Maria O'Donovan; Elizabeth Bird-Lieberman; Pradeep Bhandari; Janusz A Jankowski; Stephen Attwood; Simon L Parsons; Duncan Loft; Jesper Lagergren; Paul Moayyedi; Georgios Lyratzopoulos; John de Caestecker
Journal:  Gut       Date:  2013-10-28       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.